A single-dose study to investigate the effects of 4 different doses of inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) patients

Study identifier:D1883C00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A randomised, double-blind placebo- and active-controlled, multi-centre, 6-way cross-over, single-dose phase IIa study to investigate the bronchodilatory and systemic effects of 4 different doses of inhaled AZD8683 in patients with Chronic Obstructive Pulmonary Disease (COPD)

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD8683, Placebo, Tiotropium

Sex

All

Actual Enrollment

3

Study type

Interventional

Age

40 Years +

Date

Study Start Date: 01 Oct 2012
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria